Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
NCT02819206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225
Last updated 2023-04-21
Summary
Our research project is to use a new microbiological diagnostic strategy of uveitis, allowing detection of the fastidious pathogens of infectious Uveitis who are not diagnosed by laboratory methods used in diagnostic routine. This new diagnostic strategy is to automatically detect the presence of a pathogen fastidious in cell culture using the same patient's serum to reveal a positive culture, based on the assumption that this serum contains antibodies specific pathogen tedious.
Finally, the main purpose of this study is to improve the etiological diagnosis of Uveitis by establishing a new diagnostic strategy.
Conditions
- Uveitis
Interventions
- OTHER
-
Blood sampling
Detection of bacteria will be performed on a blood sample
Sponsors & Collaborators
-
Assistance Publique Hopitaux De Marseille
lead OTHER
Principal Investigators
-
Catherine GEINDRE · Assistance publique hôpitaux de marseille
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-07
- Primary Completion
- 2019-03-06
- Completion
- 2022-10-26
Countries
- France
Study Locations
More Related Trials
-
Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
NCT02863588 ·Status: TERMINATED ·Phase: NA
-
VCRC Patient Contact Registry Patient-Reported Data Validation Study
NCT02190942 ·Status: COMPLETED
-
Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC)
NCT03346018 ·Status: COMPLETED
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Relevance and Efficiency of SecOnd Line Workup for Uveitis
NCT06102408 ·Status: NOT_YET_RECRUITING
-
Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases
NCT02280902 ·Status: COMPLETED
-
Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
NCT07212764 ·Status: ENROLLING_BY_INVITATION
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4
-
Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein
NCT03345537 ·Status: COMPLETED
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Genetic Susceptibility Factors for Candidemia.
NCT02841501 ·Status: COMPLETED
-
Journey of Patients With Vasculitis From First Symptom to Diagnosis
NCT03410290 ·Status: COMPLETED
-
Contrast-Enhanced US of Spleen, Liver and Kidney
NCT00190281 ·Status: UNKNOWN
-
Rapid Diagnostic Test for Septic Arthritis
NCT04460144 ·Status: COMPLETED
-
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
NCT03209219 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular Leakage
NCT05015335 ·Status: UNKNOWN ·Phase: PHASE4
-
CHronic Nonbacterial Osteomyelitis International Registry
NCT04725422 ·Status: RECRUITING
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen
NCT03009708 ·Status: COMPLETED ·Phase: NA
-
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
NCT00001764 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED
-
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections
NCT06731790 ·Status: COMPLETED ·Phase: NA
-
Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
NCT07117981 ·Status: RECRUITING
-
The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
NCT01306955 ·Status: UNKNOWN ·Phase: PHASE4